Talaris_large_rgb.png
Talaris Therapeutics Announces Pricing of Initial Public Offering
May 06, 2021 21:53 ET | Talaris Therapeutics, Inc.
BOSTON and LOUISVILLE, Ky., May 06, 2021 (GLOBE NEWSWIRE) -- Talaris Therapeutics, Inc., a late-clinical stage cell therapy company developing therapies with the potential to transform the standard...